Sartorius Pref AG (SRT3)
SRT3 · Health Care · 
Germany
Sartorius Pref AG (SRT3) is a German company in the Health Care sector. The stock has its largest weight in XD5E (MSCI EMU), at 0.12%. Anyone who holds an ETF containing Sartorius Pref also has an indirect stake in the company.
Data and Charts: Sartorius Pref
Key Data for Sartorius Pref
Alysly Data Analysis: Sartorius Pref
Sartorius Pref Connections
The map shows how Sartorius Pref connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- Germany Country · domicile
- Health Care Sector · sector
- Abivax Stock · similar ETF exposure
- Sartorius Stedim Biotech Stock · similar ETF exposure
What ETF Is Sartorius Pref In?
Sartorius Pref has very high ETF coverage and is held by 26 of the 104 ETFs we track, which together follow 9 indices. That puts the stock in more ETFs than 94.3% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XD5E | MSCI EMU | 0.12% | €1.16 |
| XEMU | MSCI EMU | 0.12% | €1.16 |
| ZPRE | MSCI EMU | 0.11% | €1.10 |
| SPFS | MSCI World Health Care | 0.10% | €0.96 |
| XDWH | MSCI World Health Care | 0.09% | €0.92 |
| SPYE | MSCI Europe | 0.07% | €0.75 |
| XMEU / XIEE | MSCI Europe | 0.06% | €0.62 |
| IMEA | MSCI Europe | 0.06% | €0.60 |
| X600 / XESU | STOXX Europe 600 | 0.06% | €0.58 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.06% | €0.56 |
| EXSA | STOXX Europe 600 | 0.05% | €0.50 |
| EXUS / EXU1 | MSCI World ex USA | 0.03% | €0.35 |
| SPYY | MSCI ACWI | 0.01% | €0.12 |
| EUNL | MSCI World | 0.01% | €0.10 |
| IUSQ | MSCI ACWI | 0.01% | €0.10 |
| XDWD / XDWL | MSCI World | 0.01% | €0.09 |
| WIMI | MSCI World IMI | 0.01% | €0.06 |
| SWWD | MSCI World | 0.01% | €0.05 |
| SPPW | MSCI World | 0.01% | €0.05 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Sartorius Pref, based on each fund's latest holdings list.
Sartorius Pref Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Sartorius Pref had a weight of 0.02% on Sep 30, 2019 and 0.01% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.03% on Jun 30, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Sartorius Pref overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Sartorius Pref
| Stock | Shared ETFs | r |
|---|---|---|
| Sartorius Pref | – | – |
| Abivax | 26 | – |
| Sartorius Stedim Biotech | 26 | – |
| Eurofins Scientific | 26 | – |
| Financiere de Tubize S.A. | 26 | – |
 UCB S.A. | 26 | – |
| Biomerieux | 26 | – |
| Orion | 26 | – |
| Koninklijke Philips N.V. | 26 | – |
These stocks reach a portfolio through largely the same funds as Sartorius Pref. “Shared ETFs” counts the funds that hold both.
Fundamental Analysis: Sartorius Pref
Latest Patents Granted to Sartorius
In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, Sartorius received 21 utility patents. That is 0.007% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 5.2 years.
| Granted | Patent | Title | Filed | Technology field |
|---|---|---|---|---|
| US 12774621 B2 | Component housing for a motor vehicle lock component | E05B Fixed constructions | ||
| US 12768753 B2 | Filtration module and assembly for filtering a process medium in a bioprocess and method of sampling during a bioprocess | G01N Investigating materials | ||
| US 12703737 B2 | Recombinant proteins based on fibrinogen | C07K Chemistry; metallurgy | ||
| US 12644820 B2 | Flow cell assembly and spectroscopy device assembly for use in a bioprocess | G01N Investigating materials | ||
| US 12637654 B2 | Bioprocessing installation | C12M Chemistry; metallurgy |
These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: Sartorius Stedim Biotech GmbH and SARTORIUS LAB INSTRUMENTS GMBH & CO. KG. Titles as published by the office; median time based on 9 patents with a known filing date.
The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.
